None listed
Conditions
Interventions
Dietary Supplement : This study was a randomized, double-blinded, placebo-controlled trial to evaluate the glucose-, lipid-, and body fat-lowering effects of PT in overweight and obese subjects with m
Sponsors
Korea Research Institute of Bioscience & Biotechnology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: . Volunteers (35–65 years old), not serious disease . 27 = BMI = 23 (overweight or obese subjects) · fasting blood gluse < 126mg/dL
Exclusion criteria
Exclusion criteria: Excluded were pregnant women, type 1 diabetics, those treated with insulin and any drugs to control blood glucose, blood lipids, and body weight, diuretics to control hypertension, and those using functional food products that might affect the results of this study. Subjects were excluded if they have any diagnosis of renal disease, liver disease, thyroid disease, cerebrovascular disease, gallbladder disease, stomach and intestines disease, gout, porphyrias, and depression, schizophrenia, mental disorders such as alcoholism, drug addiction. Excluded were allergic, sathma disease, those having surgery within 6 months history, received the diagnosis and treatment of cancer within 5 years. Also, subjects were excluded if they have frequent drinking and heavy schedule that might be difficult to supplement test products.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood glucose level | — |
Secondary
| Measure | Time frame |
|---|---|
| Plasma lipid level ;Plasma cytokines-related metabolic syndrome and imflammation | — |
Countries
Korea, Republic of
Contacts
Public ContactYe Kim
Kyungpook National University
Outcome results
None listed